Correlation of residual leukocyte subsets with neutropenic fever during severe leukopenia after high-dose chemotherapy and autologous stem cell transplantation

Author： Schnabel B   Schmidmaier R   Franke D   Emmerich B   Straka C  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.8, Iss.5, 2006-11, pp. : 473-479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports

By Novik AA   Ionova TI   Bisaga GN   Kishtovich AV   Fedorenko DA   Ivanov RA   Gorodokin GI  

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 363-367

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD4++ CD28++ lymphocytes on day 5 after high-dose melphalan for multiple myeloma predict a low risk of infections during severe neutropenia and are associated with the number of reinfused T lymphocytes of the autologous stem cell graft

By Schmidmaier Ralf   Then Cornelia   Schnabel Brigitte   Oduncu Fuat   Baumann Philipp   Straka Christian  

Cytotherapy, Vol. 13, Iss. 8, 2011-09 ,pp. : 987-992

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation

By Tuma Ra   Almyroudis Ng   Sohn Sj   Panageas K   Rice Rd   Galinkin D   Blain M   Montefusco M   Pamer Eg   Nimer Sd   Kewalramani T  

Cytotherapy, Vol. 8, Iss. 4, 2006-08 ,pp. : 327-334

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cryopreserved mobilized autologous blood progenitors stored for more than 2 years successfully support blood count recovery after high-dose chemotherapy

By Cameron Giovanna   Tantiworawit Adisak   Halpenny Mike   Letcher Brenda   Berrigan Sue   Hindmarsh Karen   Giftakis Angeline   Fortier Johanne   O'Hoski Pamela   Hogge Donna  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 856-863

Ashgate Publishing Ltd

Access to resources Recommend Favorite

High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

By Braunschweig I.   Mirza N.Q.   Rondon G.   Lauppe J.   Mehra R.   Gajewski J.   Körbling M.   Huh Y.O.   Geisler D.   Gee A.P.   Champlin R.   Przepiorka D.  

Cytotherapy, Vol. 2, Iss. 2, 2000-02 ,pp. : 105-110

Ashgate Publishing Ltd

Access to resources Recommend Favorite